These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 10170288)

  • 21. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract]   [Full Text] [Related]  

  • 22. Hope for antitrust relief.
    Besaw L
    Tex Med; 1996 Jun; 92(6):26-9. PubMed ID: 8685841
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural alternatives for providers to increase managed care business and service integration.
    Tiffany BA
    Behav Healthc Tomorrow; 1994; 3(5):79-81. PubMed ID: 10141177
    [No Abstract]   [Full Text] [Related]  

  • 24. Physician-sponsored managed care networks: two suggestions for antitrust reform.
    Bierig JR
    Health Matrix Clevel; 1996; 6(1):115-28. PubMed ID: 10167163
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitrust guidelines for joint ventures and networks.
    Lauderbaugh RA
    Bull Am Coll Surg; 1996 Dec; 81(12):8-11. PubMed ID: 10163166
    [No Abstract]   [Full Text] [Related]  

  • 26. FTC weighs easing antitrust rules for provider networks.
    Gardner J
    Mod Healthc; 1995 Dec; 25(50):24. PubMed ID: 10152958
    [No Abstract]   [Full Text] [Related]  

  • 27. PSOs enable physicians to go head to head with HMOs.
    Physician Relat Update; 1997 Jun; 6(6):64-6. PubMed ID: 10167414
    [No Abstract]   [Full Text] [Related]  

  • 28. Whither antitrust? The uncertain future of competition law in health care.
    Greaney TL
    Health Aff (Millwood); 2002; 21(2):185-96. PubMed ID: 11900158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

  • 30. Will the big, bad antitrust wolf blow your IPA down?
    Pretzer M
    Med Econ; 1997 Apr; 74(7):40-4, 47. PubMed ID: 10165905
    [No Abstract]   [Full Text] [Related]  

  • 31. Converting new antitrust guidance into action.
    Johnson BA
    Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Special report on antitrust. Antitrust implications of physician practice affiliations and acquisitions: a question of market power, Part I.
    Enders RJ
    Health Care Law Newsl; 1995 Jun; 10(6):9-12. PubMed ID: 10143460
    [No Abstract]   [Full Text] [Related]  

  • 33. Establishing physician networks within evolving antitrust guidelines.
    Retchin TN; Retchin SM
    Clin Perform Qual Health Care; 1997; 5(3):140-5. PubMed ID: 10169186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating antitrust risk in joint provider negotiations with payors.
    Leonard EJ
    Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional PPO network responds to market opportunity.
    Med Netw Strategy Rep; 1997 Nov; 6(11):1-4. PubMed ID: 10175248
    [No Abstract]   [Full Text] [Related]  

  • 36. The 1996 Justice Department/FTC statements on physician joint ventures and multiprovider organizations.
    Hoffmann ER
    Med Interface; 1997 Feb; 10(2):103-6. PubMed ID: 10164786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provider sponsored organizations: a golden opportunity in Medicare managed care.
    Gleason SC; Sokolov JJ; Henshaw C
    Fam Pract Manag; 1998 Mar; 5(3):34-6, 39-42, 45. PubMed ID: 10178364
    [No Abstract]   [Full Text] [Related]  

  • 38. Increasing the marketability and recognition of provider network joint ventures.
    Sjobeck SJ
    Healthc Financ Manage; 1998 Aug; 52(8):73-6. PubMed ID: 10182281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care collaboration, antitrust, and the 1992 merger guidelines: do competition and cost effective co-operation conflict?
    Adler H
    J Health Hosp Law; 1992 Jul; 25(7):193-200. PubMed ID: 10123591
    [No Abstract]   [Full Text] [Related]  

  • 40. New antitrust rules ease restrictions on physician networks.
    Cook DA
    J Med Assoc Ga; 1996 Nov; 85(4):257-9. PubMed ID: 9276044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.